- In May 2024, Thermo Fisher Scientific Inc. announced the expansion of its operations in the United Arab Emirates through the establishment of a regional training and application support center. This facility is designed to enhance the adoption and operational efficiency of advanced analytical instruments, including mass spectrometry systems, across the Middle East. The initiative underscores Thermo Fisher’s commitment to providing localized technical support and fostering skill development among laboratory professionals in the region
- In April 2024, Agilent Technologies Inc. partnered with King Abdullah University of Science and Technology (KAUST) in Saudi Arabia to support ongoing research in metabolomics and proteomics using state-of-the-art hybrid mass spectrometry platforms. This collaboration aims to strengthen the country’s scientific capabilities in molecular diagnostics and drug discovery, contributing to the broader goal of building a knowledge-based economy under Saudi Vision 2030
- In March 2024, Waters Corporation launched a mobile mass spectrometry outreach program in South Africa in collaboration with local universities and healthcare institutions. The program is designed to promote awareness, education, and accessibility to high-resolution mass spectrometry technologies for students, researchers, and diagnostic labs in underserved areas. This initiative reflects Waters’ focus on capacity building and advancing analytical science in emerging markets
- In February 2024, Bruker Corporation announced the installation of its timsTOF Pro 2 mass spectrometer at the American University in Cairo, marking a significant upgrade in Egypt’s proteomics research capabilities. The system will be utilized for advanced biomedical and pharmaceutical studies, facilitating high-throughput analysis and biomarker discovery. This move highlights Bruker’s dedication to supporting life science research across Africa through innovative instrumentation
- In January 2024, Shimadzu Corporation expanded its distributor network across the Middle East to strengthen regional accessibility and after-sales support for its mass spectrometry product line. This strategic move aims to meet growing demand in clinical diagnostics, food safety testing, and environmental monitoring. Shimadzu’s investment in regional infrastructure demonstrates its commitment to fostering scientific excellence and market presence in the Middle East and Africa
